Risk of subsequent vitiligo in transplantation recipients with comorbid graft versus host disease: A nationwide population-based cohort study

Supplemental Figure 1. Flowchart of included patients Supplemental Table 1. Characteristics of the study population Supplemental Table 2. Subgroup analysis on the risk of vitiligo by HSCT graft type, stem cell source, and comorbid GVHD Supplemental Table 3. Risks and incidence rates of vitiligo in patients with transplantation according to a health check-up database.